ATLE
vs
S
S&P TSX Composite Index (Canada)
ATLE
Over the past 12 months, ATLE has significantly outperformed S&P TSX Composite Index (Canada), delivering a return of +520% compared to the S&P TSX Composite Index (Canada)'s +43% growth.
Stocks Performance
ATLE vs S&P TSX Composite Index (Canada)
Performance Gap
ATLE vs S&P TSX Composite Index (Canada)
Performance By Year
ATLE vs S&P TSX Composite Index (Canada)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Willow Biosciences Inc
Glance View
Willow Biosciences, Inc. is a biotechnology company. The company is headquartered in Calgary, Alberta and currently employs 49 full-time employees. The company went IPO on 2017-09-14. The firm's products include tetrahydrocannabinol (THC), cannabidiol (CBD), cannabidivarin (CBDV), cannabigerovarin (CBGV), tetrahydrocannabivarin (THCV) and cannabinol (CBN). The firm has two laboratories for research and development in Mountain View, California and Burnaby, British Columbia. In addition, the Company has an analytical testing lab in Burnaby where it provides third-party analytical testing and product development services to the cannabis industry through its subsidiary Willow Analytics Inc. The company also offers testing for all forms of cannabis products, including flower, concentrates and extracted ingredients.
